{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:45:11Z","timestamp":1785156311179,"version":"3.55.0"},"reference-count":35,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology International"],"published-print":{"date-parts":[[2022,11,28]]},"abstract":"<jats:p>Background. Real-world evidence of the efficacy and safety of ferric carboxymaltose (FCM) infusion in Indian pregnant women with iron deficiency anemia (IDA) is lacking. Objective. To assess the efficacy and safety of intravenous (IV) FCM in Indian pregnant women with IDA in 4 weeks in a real-life scenario. Methods. This is a subgroup analysis of our previously conducted retrospective, multicenter, observational, real-world PROMISE study. Data on demographic and hematological parameters, patient-reported adverse events, and physicians\u2019 clinical impressions of efficacy and safety were analysed at 4\u2009\u00b1\u20091 week. Results. This subgroup analysis included 1191 pregnant women in whom IV FCM resulted in a significant increase in hemoglobin (Hb) by 2.8\u2009g\/dL and serum ferritin by 30.03\u2009\u03bcg\/L at 4 weeks (<jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>P<\/a:mi>\n                        <a:mo>&lt;<\/a:mo>\n                        <a:mn>0.001<\/a:mn>\n                     <\/a:math>\n                  <\/jats:inline-formula> for both). In 103 pregnant women with severe IDA, there was a significant increase in Hb by 3.6\u2009g\/dL (<jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                        <c:mo>&lt;<\/c:mo>\n                        <c:mn>0.001<\/c:mn>\n                     <\/c:math>\n                  <\/jats:inline-formula>), and serum ferritin by 16.96\u2009\u03bcg\/L (<jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>=<\/e:mo>\n                        <e:mn>0.12<\/e:mn>\n                     <\/e:math>\n                  <\/jats:inline-formula>). In 978 pregnant women with moderate IDA, significant improvement in Hb by 2.74\u2009g\/dL and serum ferritin by 33\u2009\u03bcg\/L (<jats:inline-formula>\n                     <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>&lt;<\/g:mo>\n                        <g:mn>0.001<\/g:mn>\n                     <\/g:math>\n                  <\/jats:inline-formula> for both) was noted. Similarly, there was a significant increase in red blood cell count, hematocrit, mean corpuscular volume, and mean corpuscular hemoglobin (<jats:inline-formula>\n                     <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:mi>P<\/i:mi>\n                        <i:mo>&lt;<\/i:mo>\n                        <i:mn>0.001<\/i:mn>\n                     <\/i:math>\n                  <\/jats:inline-formula> for all). In pregnant women with mild IDA (n\u2009=\u200926), Hb increased significantly by 1.99\u2009g\/dL (<jats:inline-formula>\n                     <k:math xmlns:k=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\">\n                        <k:mi>P<\/k:mi>\n                        <k:mo>&lt;<\/k:mo>\n                        <k:mn>0.001<\/k:mn>\n                     <\/k:math>\n                  <\/jats:inline-formula>). Adverse effects were reported in 8.6% of pregnant women. No new safety signals or serious adverse effects were observed. Based on physicians\u2019 global assessment, good to very good efficacy and safety of IV FCM was noted in 99.2% and 98.6% of pregnant women, respectively. Conclusions. IV FCM rapidly corrected anemia in a short period of 4 weeks with favorable safety in the second and third trimester of pregnancy with all severities of IDA (severe, moderate, and mild). The physicians\u2019 favorable global assessment of FCM\u2019s efficacy and safety in pregnant women with IDA supports its use in daily clinical practice. This trial is registered with CTRI\/2021\/12\/039065.<\/jats:p>","DOI":"10.1155\/2022\/5759740","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T19:50:20Z","timestamp":1669665020000},"page":"1-7","source":"Crossref","is-referenced-by-count":14,"title":["Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnancy: A Subgroup Analysis of a Multicenter Real-World Study Involving 1191 Pregnant Women"],"prefix":"10.1155","volume":"2022","author":[{"given":"Prakash","family":"Trivedi","sequence":"first","affiliation":[{"name":"Dr. Trivedi\u2019s Total Women Health Care Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chitra","sequence":"additional","affiliation":[{"name":"Lalitha Nursing Home, Tiruchirappalli, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Ganga Medical Centre & Hospitals, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Amin","sequence":"additional","affiliation":[{"name":"Lady Care Women\u2019s Hospital & Child Care, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Sud","sequence":"additional","affiliation":[{"name":"Safal Hospital, Nagpur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Vyas","sequence":"additional","affiliation":[{"name":"Sangita Maternity Surgical and Diagnostic Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Singla","sequence":"additional","affiliation":[{"name":"Dr. Meenakshi Maternity and Child Clinic, Rohini, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajinkya","family":"Rodge","sequence":"additional","affiliation":[{"name":"Emcure Pharmaceuticals Ltd, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-7520","authenticated-orcid":true,"given":"Onkar C.","family":"Swami","sequence":"additional","affiliation":[{"name":"Emcure Pharmaceuticals Ltd, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","article-title":"Anaemia. World health organization","author":"Who","year":"2022"},{"key":"2","article-title":"Prevalence of anemia among pregnant women (%)-South Asia. World Bank","author":"World Bank","year":"2019"},{"key":"3","article-title":"NFHS 2019-21: anemia rising across all age-groups, fertility rate falls below replacement rate for first time. cnbctv18.com","author":"A. Shukla","year":"2021"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.25259\/aujmsr_8_2020"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1588_20"},{"key":"6","article-title":"Anemia mukt bharat: intensified national iron plus initiative (I-nipi): operational guidelines for programme managers","author":"Ministry of Health and Family Welfare","year":"2018"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-018-0949-6"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.2217\/whe.15.35"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14093"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.115.107896"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.4103\/ijph.ijph_409_19"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-017-0506-8"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20210321"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20192418"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.33545\/gynae.2020.v4.i3c.595"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20202325"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.4103\/0970-258x.321145"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.33545\/gynae.2020.v4.i6e.769"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-019-2200-3"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.3126\/jnhrc.v15i2.18158"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2011-0231"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-14-115"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-018-1817-y"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.04.006"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14956"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4640635"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/728952"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5060252"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4782-9"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.4103\/picr.picr_36_18"},{"key":"31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/JBM.S361210","article-title":"Efficacy and safety of ferric carboxymaltose in the management of iron deficiency anemia: a multi-center real-world study from India","volume":"13","author":"A. Charmila","year":"2022","journal-title":"Journal of Blood Medicine"},{"key":"32","volume-title":"Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Vitamin and Mineral Nutrition Information System","author":"Who","year":"2011"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1177\/156482650602700405"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601504"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0108-2"}],"container-title":["Obstetrics and Gynecology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ogi\/2022\/5759740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ogi\/2022\/5759740.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ogi\/2022\/5759740.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T19:50:24Z","timestamp":1669665024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ogi\/2022\/5759740\/"}},"subtitle":[],"editor":[{"given":"George Uchenna","family":"Eleje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":35,"alternative-id":["5759740","5759740"],"URL":"https:\/\/doi.org\/10.1155\/2022\/5759740","relation":{},"ISSN":["1687-9597","1687-9589"],"issn-type":[{"value":"1687-9597","type":"electronic"},{"value":"1687-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}